Eiger BioPharma: 2Q Earnings Snapshot
PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Friday reported a loss of $9.9 million in its second quarter.
On a per-share basis, the Palo Alto, California-based company said it had a loss of 82 cents.
The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 82 cents per share.
Eiger BioPharma shares have decreased 29 percent since the beginning of the year. The stock has climbed 28 percent in the last 12 months.